Stevanato Group S.p.A (STVN) EBITDA Margin (2020 - 2026)
Stevanato Group S.p.A (STVN) reported EBITDA Margin of 14.16% for Q1 2026, up 66.0% year-over-year from 8.53% in Q1 2025, and down 48.2% quarter-over-quarter from 27.33% in Q4 2025.
Stevanato Group S.p.A (STVN) EBITDA Margin (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of EBITDA Margin data on file, last reported at 14.16% in Q1 2026.
- EBITDA Margin for Q1 2026 came in at 14.16%, up 66.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 18.93% (up 203.0% YoY), and the FY2025 annual result was 24.23%, up 232.0% from the prior year.
- EBITDA Margin fell to 14.16% in Q1 2026 per STVN's latest filing, from 27.33% in the prior quarter.
- Over five years, EBITDA Margin peaked at 27.46% in Q4 2022 and troughed at 10.72% in Q1 2024.
- A 5-year average of 20.09% and a median of 17.87% in 2022 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2022 and 2024: EBITDA Margin soared 1301 bps in 2022, then tumbled 1445 bps in 2024.
- A 5-year view of EBITDA Margin shows it stood at 27.46% in 2022, then slipped by 4 bps to 26.23% in 2023, then retreated by 0 bps to 26.19% in 2024, then increased by 4 bps to 27.33% in 2025, then sank by 48 bps to 14.16% in 2026.
- Business Quant data shows STVN's EBITDA Margin at 14.16% in Q1 2026, 27.33% in Q4 2025, and 17.39% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 28.86% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 1.97% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 1.63% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 34.92% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 20.96% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 4.04% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -9.90% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 13.65% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.44% |
| 10 | Stevanato Group S.p.A | 433.37 Mn | 290.42 Mn | 88.01 Mn | 14.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.16% |
| Dec 31, 2025 | 27.33% |
| Sep 30, 2025 | 17.39% |
| Jun 30, 2025 | 14.77% |
| Mar 31, 2025 | 13.49% |
| Dec 31, 2024 | 26.19% |
| Sep 30, 2024 | 14.76% |
| Jun 30, 2024 | 10.77% |
| Mar 31, 2024 | 10.72% |
| Dec 31, 2023 | 26.23% |
| Sep 30, 2023 | 26.42% |
| Jun 30, 2023 | 25.23% |
| Mar 31, 2023 | 17.08% |
| Dec 31, 2022 | 27.46% |
| Sep 30, 2022 | 26.18% |
| Jun 30, 2022 | 25.53% |
| Mar 31, 2022 | 17.87% |
| Dec 31, 2021 | 25.19% |
| Sep 30, 2021 | 13.16% |
| Jun 30, 2021 | 29.91% |